StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 1/30
$17.49−0.50 (-2.78%)

Close on Nov 13, 2026Market cap $1.27BP/E –Yield –

Omeros enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Omeros's enterprise value was $1.18B on Nov 11, 2026, against $642.91M a year earlier. Over the last 5 years it ranged from -$266.51M to $1.24B, with a median of $130.20M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.18B+0.8%
2025Dec 31, 2025$1.17B+159.8%
2024Dec 31, 2024$449.34M–
2023Dec 29, 2023-$104.73M–
2022Dec 30, 2022-$79.23M-122.5%
2021Dec 31, 2021$351.75M-51.6%
2020Dec 31, 2020$727.19M+8.5%
2019Dec 31, 2019$670.47M+7.6%
2018Dec 31, 2018$623.27M-32.9%
2017Dec 29, 2017$928.72M+107.0%
2016Dec 30, 2016$448.75M-24.0%
2015Dec 31, 2015$590.81M-30.8%
2014Dec 31, 2014$853.81M+139.7%
2013Dec 31, 2013$356.25M+150.9%
2012Dec 31, 2012$141.96M+44.4%
2011Dec 30, 2011$98.34M–

More Omeros figures

See a number that looks wrong?